Skip to main content
. 2019 Apr 12;9(2):162–174. doi: 10.1002/cpdd.690

Figure 2.

Figure 2

Mean (±SD) plasma concentrations of naldemedine in subjects with mild (n = 8) or moderate (n = 8) hepatic impairment and healthy subjects with normal hepatic function (n = 8). Figure is presented in a semilogarithmic scale.